Zevra Therapeutics (ZVRA) Short Interest Ratio & Short Volume $9.10 +0.03 (+0.33%) Closing price 09/2/2025 04:00 PM EasternExtended Trading$9.22 +0.12 (+1.31%) As of 04:04 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Zevra Therapeutics Short Interest DataZevra Therapeutics (ZVRA) has a short interest of 6.36 million shares, representing 11.46% of the float (the number of shares available for trading by the public). This marks a 37.07% increase in short interest from the previous month. The short interest ratio (days to cover) is 5.4, indicating that it would take 5.4 days of the average trading volume of 1.62 million shares to cover all short positions.Current Short Interest6,360,000 sharesPrevious Short Interest4,640,000 sharesChange Vs. Previous Month+37.07%Dollar Volume Sold Short$59.97 millionShort Interest Ratio5.4 Days to CoverLast Record DateAugust 15, 2025Outstanding Shares56,130,000 sharesFloat Size55,480,000 sharesShort Percent of Float11.46%Today's Trading Volume1,007,039 sharesAverage Trading Volume1,616,205 sharesToday's Volume Vs. Average62% Short Selling Zevra Therapeutics? Sign up to receive the latest short interest report for Zevra Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartZVRA Short Interest Over TimeZVRA Days to Cover Over TimeZVRA Percentage of Float Shorted Over Time Zevra Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/15/20256,360,000 shares $59.97 million +37.1%11.5%5.4 $9.43 7/31/20254,640,000 shares $51.55 million -5.3%8.6%5.1 $11.11 7/15/20254,900,000 shares $62.67 million +166.3%9.1%6 $12.79 6/30/20251,840,000 shares $16.21 million -60.9%3.7%2.5 $8.81 6/15/20254,710,000 shares $43.00 million -16.9%8.7%8.8 $9.13 5/31/20255,670,000 shares $48.31 million -5.7%10.5%10.1 $8.52 5/15/20256,010,000 shares $50.66 million +7.3%11.1%11.3 $8.43 4/30/20255,600,000 shares $41.05 million -5.4%10.4%12.3 $7.33 4/15/20255,920,000 shares $41.20 million +0.2%10.9%12.8 $6.96 3/31/20255,910,000 shares $44.27 million +6.1%11.0%13.1 $7.49 Get the Latest News and Ratings for ZVRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Zevra Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 3/15/20255,570,000 shares $46.29 million -0.7%10.4%12 $8.31 2/28/20255,610,000 shares $44.94 million -2.9%10.6%13.1 $8.01 2/15/20255,780,000 shares $46.64 million +4.7%10.9%13.4 $8.07 1/31/20255,520,000 shares $43.28 million +0.9%10.5%10.7 $7.84 1/15/20255,470,000 shares $43.81 million +17.1%10.3%10.3 $8.01 12/31/20244,670,000 shares $38.95 million +14.7%8.8%7.7 $8.34 12/15/20244,070,000 shares $34.51 million -5.6%7.7%5.5 $8.48 11/30/20244,310,000 shares $40.21 million +4.9%8.1%5.1 $9.33 11/15/20244,110,000 shares $35.43 million +4.3%7.7%4.8 $8.62 10/31/20243,940,000 shares $32.11 million -21.2%7.5%4.6 $8.15 10/15/20245,000,000 shares $41.90 million +5.5%9.6%4.5 $8.38 9/30/20244,740,000 shares $32.90 million +25.7%9.1%4.3 $6.94 9/15/20243,770,000 shares $29.59 million -1.6%7.2%3.9 $7.85 8/31/20243,830,000 shares $29.30 million +0.3%7.3%5 $7.65 8/15/20243,820,000 shares $27.24 million -13.2%7.3%5.4 $7.13 7/31/20244,400,000 shares $28.56 million +38.8%10.6%7.2 $6.49 7/15/20243,170,000 shares $19.75 million +7.1%7.6%11.2 $6.23 6/30/20242,960,000 shares $14.50 million +7.3%7.1%12.1 $4.90 6/15/20242,760,000 shares $12.83 million +7.4%6.6%13.2 $4.65 5/31/20242,570,000 shares $11.95 million -4.1%6.2%11.8 $4.65 5/15/20242,680,000 shares $12.92 million +1.1%6.5%11.6 $4.82 4/30/20242,650,000 shares $12.14 million +11.8%6.2%10.6 $4.58 4/15/20242,370,000 shares $11.34 million +5.3%5.9%9.6 $4.79 3/31/20242,250,000 shares $13.05 million +5.6%5.6%9.1 $5.80 3/15/20242,130,000 shares $12.78 million -0.9%5.6%7.7 $6.00 2/29/20242,150,000 shares $14.49 million +0.9%5.6%7.8 $6.74 2/15/20242,130,000 shares $14.23 million No Change5.6%8.1 $6.68 1/31/20242,130,000 shares $12.33 million +1.0%5.6%8.3 $5.79 1/15/20242,110,000 shares $12.49 million +1.4%5.5%8.8 $5.92 12/31/20232,080,000 shares $13.62 million +13.7%5.5%9 $6.55Buffett, Gates and Bezos Dumping Stocks (Ad)The world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated billions of shares. Bill Gates sold 500,000 shares of Microsoft. Jeff Bezos filed to sell Amazon shares worth $4.8 billion. What is going on? One multi-millionaire believes they are preparing for a catastrophic event. But not a crash, bank run, or recession. It’s something we haven’t see in America for more than a century.For the full story, click here. 12/15/20231,830,000 shares $8.72 million -9.4%4.8%10.2 $4.77 11/30/20232,020,000 shares $9.62 million -15.1%5.4%12.6 $4.76 11/15/20232,380,000 shares $10.07 million +4.4%6.3%14.8 $4.23 10/31/20232,280,000 shares $10.21 million No Change7.0%16.3 $4.48 10/15/20232,280,000 shares $10.19 million -3.0%7.0%16.7 $4.47 9/30/20232,350,000 shares $11.33 million -10.0%7.7%16.8 $4.82 9/15/20232,610,000 shares $13.39 million +6.1%8.5%17 $5.13 8/31/20232,460,000 shares $12.47 million -3.9%8.0%10.4 $5.07 8/15/20232,560,000 shares $13.39 million +3.6%8.4%10.4 $5.23 7/31/20232,470,000 shares $12.05 million -4.3%8.1%9.1 $4.88 7/15/20232,580,000 shares $12.26 million +0.8%8.4%8.7 $4.75 6/30/20232,560,000 shares $13.06 million +20.8%8.4%8.4 $5.10 6/15/20232,120,000 shares $12.49 million +3.9%6.9%6.8 $5.89 5/31/20232,040,000 shares $10.28 million +4.1%6.7%8.3 $5.04 5/15/20231,960,000 shares $8.55 million No Change6.4%7.7 $4.36 ZVRA Short Interest - Frequently Asked Questions What is Zevra Therapeutics' current short interest? Short interest is the volume of Zevra Therapeutics shares that have been sold short but have not yet been covered or closed out. As of August 15th, traders have sold 6,360,000 shares of ZVRA short. 11.46% of Zevra Therapeutics' shares are currently sold short. Learn More on Zevra Therapeutics' current short interest. What is a good short interest ratio for Zevra Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ZVRA shares currently have a short interest ratio of 5.0. Learn More on Zevra Therapeutics's short interest ratio. Which institutional investors are shorting Zevra Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Zevra Therapeutics: Group One Trading LLC, Jane Street Group LLC, and Caption Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Zevra Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.46% of Zevra Therapeutics' floating shares are currently sold short. Is Zevra Therapeutics' short interest increasing or decreasing? Zevra Therapeutics saw a increase in short interest during the month of August. As of August 15th, there was short interest totaling 6,360,000 shares, an increase of 37.1% from the previous total of 4,640,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Zevra Therapeutics' float size? Zevra Therapeutics currently has issued a total of 56,130,000 shares. Some of Zevra Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Zevra Therapeutics currently has a public float of 55,480,000 shares. How does Zevra Therapeutics' short interest compare to its competitors? 11.46% of Zevra Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Zevra Therapeutics: Disc Medicine, Inc. (10.63%), Belite Bio, Inc. Sponsored ADR (0.59%), Mesoblast Limited (1.86%), CG Oncology, Inc. (21.99%), Adaptive Biotechnologies Corporation (5.88%), ANI Pharmaceuticals, Inc. (10.14%), Dyne Therapeutics, Inc. (12.05%), Arcutis Biotherapeutics, Inc. (15.35%), Vericel Corporation (11.16%), Sarepta Therapeutics, Inc. (18.67%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Lucid Group, Inc. ($8.00 billion), Spotify Technology ($5.48 billion), AppLovin Corporation ($5.11 billion), Reddit Inc. ($5.02 billion), Coinbase Global, Inc. ($3.99 billion), Charter Communications, Inc. ($3.89 billion), Live Nation Entertainment, Inc. ($3.18 billion), Seagate Technology Holdings PLC ($2.59 billion), ResMed Inc. ($2.55 billion), and Rocket Lab Corporation ($2.52 billion). View all of the most shorted stocks. What does it mean to sell short Zevra Therapeutics stock? Short selling ZVRA is an investing strategy that aims to generate trading profit from Zevra Therapeutics as its price is falling. ZVRA shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Zevra Therapeutics? A short squeeze for Zevra Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ZVRA, which in turn drives the price of the stock up even further. How often is Zevra Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ZVRA, twice per month. The most recent reporting period available is August, 15 2025. More Short Interest Resources from MarketBeat Related Companies Disc Medicine Short Interest Belite Bio Short Interest Mesoblast Short Interest CG Oncology Short Interest Adaptive Biotechnologies Short Interest ANI Pharmaceuticals Short Interest Dyne Therapeutics Short Interest Arcutis Biotherapeutics Short Interest Vericel Short Interest Sarepta Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ZVRA) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredDid you spot this in the Oval Office last week?When Tim Cook stood in the Oval Office last week, all eyes were on the "unique 24K gold gift" he presented to ...InvestorPlace | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zevra Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zevra Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.